The following definitions apply to this part, unless the context indicates otherwise:
Actuarial equivalence means a state of equivalent value demonstrated through the use of generally accepted actuarial principles and in accordance with section 1860D-11(c) of the Act and with CMS actuarial guidelines.
Brand name drug means a drug for which an application is approved under section 505(c) of the Federal Food, Drug, and Cosmetic Act (21 USC 355(c)), including an application referred to in section 505(b)(2) of the Federal Food, Drug and Cosmetic Act (21 USC 355(b)(2)).
Cost plan means a plan operated by a Health Maintenance Organization (HMO) or Competitive Medical Plan (CMP) in accordance with a cost-reimbursement contract under section 1876(h) of the Act.
Downstream entity means any party that enters into a written arrangement, acceptable to CMS, with persons or entities involved with the Part D benefit, below the level of the arrangement between a Part D plan sponsor (or applicant) and a first tier entity. These written arrangements continue down to the level of the ultimate provider of both health and administrative services.
Eligible fallback entity or fallback entity is defined at Sec. 423.855.
Fallback prescription drug plan is defined at Sec. 423.855.
First tier entity means any party that enters into a written arrangement, acceptable to CMS, with a Part D plan sponsor or applicant to provide administrative services or health care services for a Medicare eligible individual under Part D.
Fiscally sound operation means an operation which at least maintains a positive net worth (total assets exceed total liabilities).
Formulary means the entire list of Part D drugs covered by a Part D plan.
Full-benefit dual eligible individual has the meaning given the term at Sec. 423.772, except where otherwise provided.
Generic drug means a drug for which an application under section 505(j) of the Federal Food, Drug, and Cosmetic Act (21 USC 355(j)) is approved.
Group health plan is defined at Sec. 423.882.
Insurance risk means, for a participating pharmacy, risk of the type commonly assumed only by insurers licensed by a State and does not include payment variations designed to reflect performance-based measures of activities within the control of the pharmacy, such as formulary compliance and generic drug substitutions, nor does it include elements potentially in the control of the pharmacy (for example, labor costs or productivity).
MA stands for Medicare Advantage, which refers to the program authorized under Part C of title XVIII of the Act.
MA plan has the meaning given the term in Sec. 422.2 of this chapter.
MA-PD plan means an MA plan that provides qualified prescription drug coverage.
Medicare prescription drug account means the account created within the Federal Supplementary Medical Insurance Trust Fund for purposes of Medicare Part D.
Monthly beneficiary premium means the amount calculated under Sec. 423.286 for Part D plans other than fallback prescription drug plans, and Sec. 423.867(a) for fallback prescription drug plans.
PACE Plan means a plan offered by a PACE organization.
PACE organization is defined in Sec. 460.6 of this chapter.
Part D eligible individual means an individual who meets the requirements at Sec. 423.30(a).
Part D plan (or Medicare Part D plan) means a prescription drug plan, an MA-PD plan, a PACE Plan offering qualified prescription drug coverage, or a cost plan offering qualified prescription drug coverage.
Part D plan sponsor or Part D sponsor refers to a PDP sponsor, MA organization offering a MA-PD plan, a PACE organization offering a PACE plan including qualified prescription drug coverage, and a cost plan offering qualified prescription drug coverage.
PDP region means a prescription drug plan region as determined by CMS under Sec. 423.112.
PDP sponsor means a nongovernmental entity that is certified under this part as meeting the requirements and standards of this part that apply to entities that offer prescription drug plans. This includes fallback entities.
Pharmacist means any individual who holds a current valid license to practice pharmacy in a State or territory of the United States or the District of Columbia.
Prescription drug plan or PDP means prescription drug coverage that is offered under a policy, contract, or plan that has been approved as specified in Sec. 423.272 and that is offered by a PDP sponsor that has a contract with CMS that meets the contract requirements under subpart K of this part. This includes fallback prescription drug plans.
Related entity means any entity that is related to the Part D sponsor by common ownership or control and
(1) Performs some of the Part D plan sponsor's management functions under contract or delegation;
(2) Furnishes services to Medicare enrollees under an oral or written agreement; or
(3) Leases real property or sells materials to the Part D plan sponsor at a cost of more than $2,500 during a contract period.
Service area (Service area does not include facilities in which individuals are incarcerated.) means for--
(1) A prescription drug plan, an area established in Sec. 423.112(a) within which access standards under Sec. 423.120(a) are met;
(2) An MA-PD plan, an area that meets the definition of MA service area as described in Sec. 422.2 of this chapter, and within which access standards under Sec. 423.120(a) are met;
(3) A fallback prescription drug plan, the service area described in Sec. 423.859(b);
(4) A PACE plan offering qualified prescription drug coverage, the service area described in Sec. 460.22 of this chapter; and
(5) A cost plan offering qualified prescription drug coverage, the service area defined in Sec. 417.1 of this chapter.
Subsidy-eligible individual means a full subsidy eligible individual (as defined at Sec. 423.772) or other subsidy eligible individual (as defined at Sec. 423.772).
Tiered cost-sharing means a process of grouping Part D drugs into different cost sharing levels within a Part D sponsor's formulary. [70 FR 4525, Jan. 28, 2005, as amended at 72 FR 68731, Dec. 5, 2007; 76 FR 21570, Apr. 15, 2011]